Literature DB >> 27178322

Quorum-sensing inhibition abrogates the deleterious impact of Pseudomonas aeruginosa on airway epithelial repair.

Manon Ruffin1, Claudia Bilodeau1, Émilie Maillé2, Shantelle L LaFayette3, Geoffrey A McKay3, Nguyen Thu Ngan Trinh1, Trevor Beaudoin3, Martin-Yvon Desrosiers2, Simon Rousseau3, Dao Nguyen3, Emmanuelle Brochiero4.   

Abstract

Chronic Pseudomonas aeruginosa lung infections are associated with progressive epithelial damage and lung function decline. In addition to its role in tissue injury, the persistent presence of P. aeruginosa-secreted products may also affect epithelial repair ability, raising the need for new antivirulence therapies. The purpose of our study was to better understand the outcomes of P. aeruginosa exoproducts exposure on airway epithelial repair processes to identify a strategy to counteract their deleterious effect. We found that P. aeruginosa exoproducts significantly decreased wound healing, migration, and proliferation rates, and impaired the ability of directional migration of primary non-cystic fibrosis (CF) human airway epithelial cells. Impact of exoproducts was inhibited after mutations in P. aeruginosa genes that encoded for the quorum-sensing (QS) transcriptional regulator, LasR, and the elastase, LasB, whereas impact was restored by LasB induction in ΔlasR mutants. P. aeruginosa purified elastase also induced a significant decrease in non-CF epithelial repair, whereas protease inhibition with phosphoramidon prevented the effect of P. aeruginosa exoproducts. Furthermore, treatment of P. aeruginosa cultures with 4-hydroxy-2,5-dimethyl-3(2H)-furanone, a QS inhibitor, abrogated the negative impact of P. aeruginosa exoproducts on airway epithelial repair. Finally, we confirmed our findings in human airway epithelial cells from patients with CF, a disease featuring P. aeruginosa chronic respiratory infection. These data demonstrate that secreted proteases under the control of the LasR QS system impair airway epithelial repair and that QS inhibitors could be of benefit to counteract the deleterious effect of P. aeruginosa in infected patients.-Ruffin, M., Bilodeau, C., Maillé, É., LaFayette, S. L., McKay, G. A., Trinh, N. T. N., Beaudoin, T., Desrosiers, M.-Y., Rousseau, S., Nguyen, D., Brochiero, E. Quorum-sensing inhibition abrogates the deleterious impact of Pseudomonas aeruginosa on airway epithelial repair. © FASEB.

Entities:  

Keywords:  LasB elastase; LasR; cystic fibrosis; furanone QSI; infection

Mesh:

Substances:

Year:  2016        PMID: 27178322      PMCID: PMC6191002          DOI: 10.1096/fj.201500166R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  59 in total

1.  Phosphoramidon as an inhibitor of elastase from Pseudomonas aeruginosa.

Authors:  K Morihara; H Tsuzuki
Journal:  Jpn J Exp Med       Date:  1978-02

2.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

3.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients.

Authors:  Dieter Worlitzsch; Robert Tarran; Martina Ulrich; Ute Schwab; Aynur Cekici; Keith C Meyer; Peter Birrer; Gabriel Bellon; Jürgen Berger; Tilo Weiss; Konrad Botzenhart; James R Yankaskas; Scott Randell; Richard C Boucher; Gerd Döring
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

4.  Pseudomonas aeruginosa ExoT inhibits in vitro lung epithelial wound repair.

Authors:  T K Geiser; B I Kazmierczak; L K Garrity-Ryan; M A Matthay; J N Engel
Journal:  Cell Microbiol       Date:  2001-04       Impact factor: 3.715

5.  Deleterious impact of Pseudomonas aeruginosa on cystic fibrosis transmembrane conductance regulator function and rescue in airway epithelial cells.

Authors:  Nguyen Thu Ngan Trinh; Claudia Bilodeau; Émilie Maillé; Manon Ruffin; Marie-Claude Quintal; Martin-Yvon Desrosiers; Simon Rousseau; Emmanuelle Brochiero
Journal:  Eur Respir J       Date:  2015-03-18       Impact factor: 16.671

6.  Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration.

Authors:  R S Baltimore; C D Christie; G J Smith
Journal:  Am Rev Respir Dis       Date:  1989-12

Review 7.  Why chronic wounds will not heal: a novel hypothesis.

Authors:  Thomas Bjarnsholt; Klaus Kirketerp-Møller; Peter Østrup Jensen; Kit G Madsen; Richard Phipps; Karen Krogfelt; Niels Høiby; Michael Givskov
Journal:  Wound Repair Regen       Date:  2008 Jan-Feb       Impact factor: 3.617

8.  Secreted biofilm factors adversely affect cellular wound healing responses in vitro.

Authors:  Robert Jeffery Marano; Hilary Jane Wallace; Dulharie Wijeratne; Mark William Fear; Hui San Wong; Ryan O'Handley
Journal:  Sci Rep       Date:  2015-08-17       Impact factor: 4.379

Review 9.  Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis.

Authors:  Matthew N Hurley; Miguel Cámara; Alan R Smyth
Journal:  Eur Respir J       Date:  2012-06-27       Impact factor: 16.671

10.  Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient.

Authors:  Matthew L Workentine; Christopher D Sibley; Bryan Glezerson; Swathi Purighalla; Jens C Norgaard-Gron; Michael D Parkins; Harvey R Rabin; Michael G Surette
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more
  14 in total

1.  The bacterial quorum-sensing molecule, N-3-oxo-dodecanoyl-L-homoserine lactone, inhibits mediator release and chemotaxis of murine mast cells.

Authors:  Ibrahim Khambati; Sangsu Han; Daniëlle Pijnenburg; Hannah Jang; Paul Forsythe
Journal:  Inflamm Res       Date:  2016-11-28       Impact factor: 4.575

Review 2.  Virulence Factor Targeting of the Bacterial Pathogen Staphylococcus aureus for Vaccine and Therapeutics.

Authors:  Trevor L Kane; Katelyn E Carothers; Shaun W Lee
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

3.  Quorum Sensing Down-Regulation Counteracts the Negative Impact of Pseudomonas aeruginosa on CFTR Channel Expression, Function and Rescue in Human Airway Epithelial Cells.

Authors:  Émilie Maillé; Manon Ruffin; Damien Adam; Hatem Messaoud; Shantelle L Lafayette; Geoffrey McKay; Dao Nguyen; Emmanuelle Brochiero
Journal:  Front Cell Infect Microbiol       Date:  2017-11-10       Impact factor: 5.293

Review 4.  Repair Process Impairment by Pseudomonas aeruginosa in Epithelial Tissues: Major Features and Potential Therapeutic Avenues.

Authors:  Manon Ruffin; Emmanuelle Brochiero
Journal:  Front Cell Infect Microbiol       Date:  2019-05-31       Impact factor: 5.293

5.  Dexamethasone fails to improve bleomycin-induced acute lung injury in mice.

Authors:  Mélissa Aubin Vega; Cécile Chupin; Mihai Pascariu; Anik Privé; André Dagenais; Yves Berthiaume; Emmanuelle Brochiero
Journal:  Physiol Rep       Date:  2019-11

Review 6.  Roles of Two-Component Systems in Pseudomonas aeruginosa Virulence.

Authors:  Maria Sultan; Rekha Arya; Kyeong Kyu Kim
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

7.  SLC6A14 Impacts Cystic Fibrosis Lung Disease Severity via mTOR and Epithelial Repair Modulation.

Authors:  Julia Mercier; Claire Calmel; Julie Mésinèle; Erika Sutanto; Fatiha Merabtene; Elisabeth Longchampt; Edouard Sage; Anthony Kicic; Pierre-Yves Boëlle; Harriet Corvol; Manon Ruffin; Loïc Guillot
Journal:  Front Mol Biosci       Date:  2022-03-09

Review 8.  Pathophysiology of Lung Disease and Wound Repair in Cystic Fibrosis.

Authors:  Massimo Conese; Sante Di Gioia
Journal:  Pathophysiology       Date:  2021-03-10

9.  Imaging viscosity of intragranular mucin matrix in cystic fibrosis cells.

Authors:  Sebastian Requena; Olga Ponomarchuk; Marlius Castillo; Jonathan Rebik; Emmanuelle Brochiero; Julian Borejdo; Ignacy Gryczynski; Sergei V Dzyuba; Zygmunt Gryczynski; Ryszard Grygorczyk; Rafal Fudala
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

10.  Pseudomonas aeruginosa LasB Subverts Alveolar Macrophage Activity by Interfering With Bacterial Killing Through Downregulation of Innate Immune Defense, Reactive Oxygen Species Generation, and Complement Activation.

Authors:  Fabien Bastaert; Saadé Kheir; Vinciane Saint-Criq; Bérengère Villeret; Pham My-Chan Dang; Jamel El-Benna; Jean-Claude Sirard; Romé Voulhoux; Jean-Michel Sallenave
Journal:  Front Immunol       Date:  2018-07-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.